Sanex Pharmaceuticals Limited - Company Profile

It is a pharma public limited company based in Kol-700017, West Bengal, India, established in 2006.
2006 Kol-700017, West Bengal, India Active
Last Updated:
About Sanex Pharmaceuticals Limited

Sanex Pharmaceuticals Limited, a active public limited company, was established on 14 July 2006 in Kol-700017, West Bengal, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U24232WB2006PLC110613. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.

It upholds a compliant status. Its leadership includes Raj Kumar Todi (Director), Dhruv Todi (Director), Sangita Todi (Director). Past directors included Rishi Todi, Varun Todi, Sangita Todi. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 12, Darga Road, Ground Floor,Kol-700017, Kol-700017, West Bengal.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232WB2006PLC110613

  • Registration Number

    110613

  • Incorporation Date

    14 July 2006

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹1.00 M

  • ROC Code

    Roc Kolkata

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 1.00 M
  • Company Age 19 Year, 10 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** -45.59%
  • Profit Growth **** -550.93%
  • Ebitda **** -7665.69%
  • Net Worth -1.76%
  • Total Assets -0.48%
Company report

Sanex Pharmaceuticals Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Sanex Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Sanex Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Raj Kumar Todi Director 14 Jul 2006 Current
Dhruv Todi Director 10 Oct 2006 Current
Sangita Todi Director 13 Sep 2010 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 13 Sep 2010 Past
Pramod Abcsdd Director 13 Sep 2010 Past
Pramod Abcsdd Additional Director 30 Sep 2010 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sanex Pharmaceuticals.

Sanex Pharmaceuticals Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 45.59% decrease. The company also saw a substantial fall in profitability, with a 550.93% decrease in profit. The company's net worth dipped by a decrease of 1.76%.

Sanex Pharmaceuticals revenue growth over time
Sanex Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
-45.59%
*******
*******
*******
*******
Revenue from Operations
*******
-100.00%
*******
*******
*******
*******
Total Assets
*******
-0.48%
*******
*******
*******
*******
Profit or Loss
*******
-550.93%
*******
*******
*******
*******
Net Worth
*******
-1.76%
*******
*******
*******
*******
EBITDA
*******
-7665.69%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sanex Pharmaceuticals?

In 2023, Sanex Pharmaceuticals had a promoter holding of 85.18% and a public holding of 14.82%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Sanex Pharmaceuticals?

Unlock and access historical data on people associated with Sanex Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sanex Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanex Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sanex Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Sanex Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Sanex Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata. was recorded as a recent event.

  • Director Appointment

    Sangita Todi was appointed as a Director was appointed as a Director on 13 Sep 2010 & has been associated with this company since 15 years 8 months . was recorded as a recent event.

  • Director Appointment

    Progress on Dhruv Todi was appointed as a Director was appointed as a Director on 10 Oct 2006 & has been associated with this company since 19 years 7 months . was documented.

  • Director Appointment

    The activity Raj Kumar Todi was appointed as a Director was appointed as a Director on 14 Jul 2006 & has been associated with this company since 19 years 10 months . was completed.

  • Company Incorporation

    The activity Sanex Pharmaceuticals Limited was registered on 14 Jul 2006 with Roc Kolkata & aged 19 years 10 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Sanex Pharmaceuticals Limited?

The CIN of Sanex Pharmaceuticals Limited is U24232WB2006PLC110613.

Where is Sanex Pharmaceuticals Limited headquartered?

Sanex Pharmaceuticals Limited is headquartered at 12, Darga Road, Ground Floor,Kol-700017, Kol-700017, West Bengal.

When was Sanex Pharmaceuticals Limited incorporated?

Sanex Pharmaceuticals Limited was incorporated on 14 July 2006.

Who are the current directors of Sanex Pharmaceuticals Limited?

The current directors of Sanex Pharmaceuticals Limited are

What is the primary industry of Sanex Pharmaceuticals Limited?

The primary industry of Sanex Pharmaceuticals Limited is Manufacturing.

Is Sanex Pharmaceuticals Limited a listed company?

Sanex Pharmaceuticals Limited is unlisted.

What is the capital structure of Sanex Pharmaceuticals Limited?

The authorized capital of Sanex Pharmaceuticals Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.

What is the compliance status of Sanex Pharmaceuticals Limited?

The compliance status of Sanex Pharmaceuticals Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available